Oral Care to Reduce Mouth and Throat Infections in Critically Ill Patients
The Effect of a Systemic Oral Care Program on Reducing Exposure to Oropharyngeal Pathogens in Critically III Patients
2 other identifiers
interventional
800
1 country
5
Brief Summary
This study will evaluate whether a program of systematic oral care can help prevent hospital-acquired respiratory infections in patients in intensive care units. Such infections occur five times more often in critically ill patients compared with patients in general hospital wards and result in longer hospital stays and an increased risk of death. The rate of respiratory infection among critically ill patients correlates strongly with the presence of disease-causing bacteria in the mucosal areas of the mouth, gums, and teeth, indicating that assiduous oral care is especially important in this patient population. This study will compare a program of meticulous oral care using oral assessments taught by a dentist and dental hygienist with the standard care typically given in intensive care units. Critically ill patients 18 years of age and older who are hospitalized in an intensive care unit for 3 or more days and whose oral hygiene is dependent on hospital care providers may be eligible for this study. Patients will be recruited from intensive care units at four Washington, D.C., area hospitals - Suburban Hospital, Washington Hospital Center, Inova Fairfax Hospital, and Winchester Medical Center. Participants will have their lips, mouth, gums, teeth, and saliva examined several times a day to determine their optimum oral care. They will receive standard care, such as flossing, brushing, rinsing with a mouthwash, and possibly use of an antiseptic spray that prevents bacteria from clinging to the teeth. Small samples of saliva (less than one-fourth of a teaspoon) and dental plaque will be collected the day the patient is admitted to the intensive care unit and again on days 3 and 5 of their stay in the unit. The saliva sample is collected with a small suction tube placed in the corner of the mouth; the plaque specimen is collected by gliding a tiny piece of paper over the surface of a front tooth. The samples will be examined for any bacteria not normally found in saliva.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Mar 2004
Longer than P75 for phase_3
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 2, 2004
CompletedFirst Submitted
Initial submission to the registry
March 3, 2004
CompletedFirst Posted
Study publicly available on registry
March 4, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
August 16, 2011
CompletedJuly 2, 2017
August 16, 2011
3.8 years
March 3, 2004
June 30, 2017
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Male or female adult ICU patients whose oral hygiene is dependent upon hospital care providers.
- Expected length of ICU stay is greater than or equal to 3 days.
- Any gender and ethnicity.
You may not qualify if:
- Individuals and or responsible family members who are unable to provide consent.
- Any individual under the age of 18 years.
- Any individual whose expected admission is less than 3 days.
- Adult ICU patients whose admission CPIS score is greater than 6.
- Individuals who are able to provide own oral care.
- Individuals who have oral surgery that requires specialized oral care and assessment.
- Edentulous patients.
- Any patient with a prosthetic heart valve or who routinely takes prophylactic antibiotics before routine dental procedures.
- Any patient with a known allergy to chlorhexidine.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Suburban Hospital
Bethesda, Maryland, 20814, United States
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Inova Fairfax Hospital
Fairfax, Virginia, United States
Winchester Medical Center
Winchester, Virginia, United States
Related Publications (3)
Collard HR, Saint S, Matthay MA. Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann Intern Med. 2003 Mar 18;138(6):494-501. doi: 10.7326/0003-4819-138-6-200303180-00015.
PMID: 12639084BACKGROUNDValles J, Mesalles E, Mariscal D, del Mar Fernandez M, Pena R, Jimenez JL, Rello J. A 7-year study of severe hospital-acquired pneumonia requiring ICU admission. Intensive Care Med. 2003 Nov;29(11):1981-8. doi: 10.1007/s00134-003-2008-4. Epub 2003 Sep 10.
PMID: 13680109BACKGROUNDEggimann P, Hugonnet S, Sax H, Touveneau S, Chevrolet JC, Pittet D. Ventilator-associated pneumonia: caveats for benchmarking. Intensive Care Med. 2003 Nov;29(11):2086-9. doi: 10.1007/s00134-003-1991-9. Epub 2003 Sep 3.
PMID: 12955177BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
March 3, 2004
First Posted
March 4, 2004
Study Start
March 2, 2004
Primary Completion
December 28, 2007
Study Completion
August 16, 2011
Last Updated
July 2, 2017
Record last verified: 2011-08-16